AEON Biopharma, Inc.
AEON · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,538 | -$6,642 | $9,095 | $2,082 |
| Dep. & Amort. | $19 | $20 | $19 | $23 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,582 | $1,729 | $1,342 |
| Change in WC | $814 | $537 | -$5,810 | $3,295 |
| Other Non-Cash | $1,109 | $2,412 | -$12,942 | -$7,363 |
| Operating Cash Flow | -$2,596 | -$2,091 | -$7,909 | -$621 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$4 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$4 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $84 | $84 | $18,346 | $97 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $84 | $84 | $18,346 | $97 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,512 | -$2,007 | $10,433 | -$524 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,439 | $10,446 | $13 | $537 |
| End Cash | $5,927 | $8,439 | $10,446 | $13 |
| Free Cash Flow | -$2,596 | -$2,091 | -$7,913 | -$621 |